Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds
Cytotoxicity of de novo purine synthesis (DNPS) metabolites is critical to the pathogenesis of three known and one putative autosomal recessive disorder affecting DNPS. These rare disorders are caused by biallelic mutations in the DNPS genes phosphoribosylformylglycineamidine synthase (PFAS), phosph...
Main Authors: | Olga Souckova, Vaclava Skopova, Veronika Baresova, David Sedlak, Anthony J. Bleyer, Stanislav Kmoch, Marie Zikanova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/12/1210 |
Similar Items
-
Yeast to Study Human Purine Metabolism Diseases
by: Bertrand Daignan-Fornier, et al.
Published: (2019-01-01) -
The Key Role of Purine Metabolism in the Folate-Dependent Phenotype of Autism Spectrum Disorders: An In Silico Analysis
by: Jan Geryk, et al.
Published: (2020-05-01) -
Combined Targeted and Untargeted Profiling of HeLa Cells Deficient in Purine De Novo Synthesis
by: Lucie Mádrová, et al.
Published: (2022-03-01) -
Pathway-specific effects of ADSL deficiency on neurodevelopment
by: Ilaria Dutto, et al.
Published: (2022-02-01) -
Novel Substituted Purine Isosteres: Synthesis, Structure-Activity Relationships and Cytotoxic Activity Evaluation
by: Spyridon Dimitrakis, et al.
Published: (2021-12-01)